Two Onc Docs

Metastatic Breast Cancer 2023 UPDATE

Oct 30, 2023
The podcast provides an update on metastatic breast cancer focusing on systemic therapy and toxicities. It discusses side effects of CDK46 inhibitors, dosing schedules, and second-line treatment options. Various chemotherapy options for metastatic breast cancer and approaches for HER2 positive and triple negative breast cancer are explored. The role of bone protective agents and the importance of clinical trials are also discussed.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Side effects of CDK46 inhibitors, dosing schedules, and second-line treatment options for ERPR positive metastatic breast cancer
01:58 • 2min
3
Treatment Options for Metastatic Breast Cancer
04:13 • 3min
4
Treatment Options for Metastatic Triple Negative Breast Cancer
06:48 • 2min
5
Role of Bone Protective Agents in Metastatic Breast Cancer and Treatment Approaches
09:01 • 2min